01 September 2005
Systemic Lupus Erythematosus (SLE) in Italy: an Italian prevalence study basedon a two-step strategy in an area of Florence (Scandicci-Le Signe).
Maurizio Benucci, Angela Del Rosso, Francesca Li Gobbi, Mariangela Manfredi, Marco Matucci Cerinic, Carlo SalvaraniMed Sci Monit 2005; 11(9): CR420-425 :: ID: 428449
Abstract
Background: The goal was to ascertain the prevalence of SLE in the populationover18 years of age in the Scandicci-Le Signe area of Florence, Italy, based on the records of generalpractitioners (GPs). Material/Methods: Twenty GPs screened 32,521 patients by administering the LupusScreening Questionnaire (LQS) and found 30 patients with suspected or definite diagnosis of SLE. To confirmthe diagnoses the patients were referred to a rheumatologist who conducted routine examinations and assessedantinuclear antibodies and SLE activity (ECLAM score). Results: Total population >18 years of age inthe three municipalities was 71,204 persons, with 42,474 in Scandicci, 15,368 in Lastra a Signa, and13,362 in Signa. In 23/30 patients diagnosed with SLE the diagnosis was confirmed. Eleven of the 23 SLEpatients were from Scandicci and 6 each from Lastra a Signa and Signa. An overall estimated prevalenceof SLE of 71/100,000 (1/1408; 95% CI=49, 92) was found in the total population of the three municipalities.Scandicci (95% CI=42, 121) had a rate of 81/100.000, while Lastra a Signa (95% CI=32, 92) and Signa (95%CI=36, 94) had estimated rates of 62/100,000 and 65/100,000, respectively. Medium ECLAM score was 4.68+/-1.81SD. Conclusions: This is the first epidemiological study on SLE prevalence in Italy. The prevalence andpoint prevalence are similar to other European studies. The LQS was also confirmed as an easy and reliabletool to assess SLE diagnosis in the Italian population.
Keywords: Family Practice, Italy - epidemiology, Lupus Erythematosus, Systemic - epidemiology, Mass Screening, Questionnaires, Rheumatology
662 19
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
08 Jun 2023 : Clinical Research
Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical Research
A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical Research
Burden of COVID-19 on Mental Health of Resident Doctors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical Research
Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952